MMCM
ELAN icon

Murphy & Mullick Capital Management’s Elanco Animal Health ELAN Stock Holding History

Murphy & Mullick Capital Management’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.3K Sell
500
-36
-7% -$832 0.01% 467
2026
Q1 		$12.8K Hold
536
– – 0.01% 446
2025
Q4 		$12.1K Buy
536
+36
+7% +$783 0.01% 458
2025
Q3 		$11.3K Buy
+500
New +$8.38K 0.01% 453

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Murphy & Mullick Capital Management's ELAN Position: Q2 2026 in Review

Murphy & Mullick Capital Management reduced its Elanco Animal Health (ELAN) stake by 6.7% in Q2 2026, selling an estimated $832 and leaving 500 shares worth $12.3K. The position accounts for 0.01% of the portfolio, ranked #467.

Murphy & Mullick Capital Management first reported a position in ELAN in Q3 2025 and has held it in 4 quarters since. The position peaked at $12.8K in Q1 2026. 522 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Murphy & Mullick Capital Management held 500 shares of Elanco Animal Health worth $12.3K as of Q2 2026.
  • Murphy & Mullick Capital Management sold 36 Elanco Animal Health shares in Q2 2026, an estimated $832.
  • Elanco Animal Health made up 0.01% of Murphy & Mullick Capital Management's portfolio in Q2 2026, its #467 holding.
  • Murphy & Mullick Capital Management first reported a position in Elanco Animal Health in Q3 2025 and has held it in 4 quarters since.
  • Murphy & Mullick Capital Management's Elanco Animal Health position peaked at $12.8K in Q1 2026.
  • 522 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.